Description
Book SynopsisThe second volume of this book series on the modern practice of Chinese medicine continues with the focus on evidence-based TCM research. It is focused on detailed information about the best sources of herbal supply and its quality control required for research and drug development purposes. Herbal quality has always been a major concern for TCM researchers because it is difficult to know which is of the best quality. Some other popular topics are also entertained.
Table of ContentsThe Basic Requirement for Modernization of Chinese Herbal Medicine -- Quality Controllable (P Xie); Quality Control of Herbs: Principles and Procedures, Using Panax as an Example (H L Koh); DNA Profiling for Quality Control of Medical Herbs, Utilities and Issues (Y Hong); Modern FT-IR Spectroscopy and Quality Control of TCMs (S Sun); GLP Requirements and Herbal Medicines (K-F Cheng et al.); The Recognition and Challenge of Drug Metabolism and Pharmacokinetics in Modernization Research of TCMs (C-X Liu); Intestinal Metabolism of Traditional Chinese Medicine and Its Pharmacological and Toxicological Significance (G-Z Han); Research on Depth and Angle of Dangerous Acupoints (Z Yan); Acupuncture in Cancer Patient Care (G Deng & B R Cassileth); Observation of the Effect of a Herbal Formula in Anti-metastasis of Post-Operation Colorectal Cancer (H-C Shen); Evaluation of Research on Diabetes with Combined TCM and Western Medicine (L Lin); Evidence-based Herbal Medicine: Challenges in Efficacy and Safety Assessment (H Fong); GAP in China (P C Leung); Review on the Supply and Growth of Medicinal Herbs in Japan (Z Zhao); Evidence Reports of Kampo Treatment (T Akiba).
